US FDA Advisory Committee Drought Is Over … Unless Sponsors Are Scared Of Dark Clouds
Executive Summary
FDA has three NDAs set for public advisory committee review at the end of March and early April, the first 'real' committee meetings in five months. Oops. Make that two.